参考文献/References:
[1] Anakwe OO,Gerton GL.Acrosome biogenesis begins during meiosis:evidence from the synthesis and distribution of an acrosomal glycoprotein,acrogranin,during guinea pig spermatogenesis[J].Biol Reprod,1990,42(2):317-328.
[2] Zhu Y,Ohama T,Kawase R,et al.Progranulin deficiency leads to enhanced age-related cardiac hypertrophy through complement C1q-induced beta-catenin activation[J].J Mol Cell Cardiol,2019(138):197-211.
[3] Jing C,Zhang X,Song Z,et al.Progranulin mediates proinflammatory responses in systemic lupus erythematosus:implications for the pathogenesis of systemic lupus erythematosus[J].J Interferon Cytokine Res,2020,40(1):33-42.
[4] Albeltagy ES,Hammour AE,Albeltagy SA.Potential value of serum Progranulin as a biomarker for the presence and severity of micro vascular complications among Egyptian patients with type 2 diabetes mellitus[J].J Diabetes Metab Disord,2019,18(1):217-228.
[5] 徐 琳,贾睿博,宋民喜,等.颗粒蛋白前体与糖尿病肾病关系探讨[J].陕西医学杂志,2019,48(8):1024-1027.
[6] Kao AW,McKay A,Singh PP,et al.Progranulin,lysosomal regulation and neurodegenerative disease[J].Nat Rev Neurosci,2017,18(6):325-333.
[7] Arechavaleta-Velasco F,Perez-Juarez CE,Gerton GL,et al.Progranulin and its biological effects in cancer[J].Med Oncol,2017,34(12):194.
[8] He Z,Bateman A.Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo[J].Cancer Res,1999,59(13):3222-3229.
[9] Matsumura N,Mandai M,Miyanishi M,et al.Oncogenic property of acrogranin in human uterine leiomyosarcoma:direct evidence of genetic contribution in in vivo tumorigenesis[J].Clin Cancer Res,2006,12(5):1402-1411.
[10] Miyanishi M,Mandai M,Matsumura N,et al.Immortalized ovarian surface epithelial cells acquire tumorigenicity by Acrogranin gene overexpression[J].Oncol Rep,2007,17(2):329-333.
[11] Lu Y,Zheng L,Zhang W,et al.Growth factor progranulin contributes to cervical cancer cell proliferation and transformation in vivo and in vitro[J].Gynecol Oncol,2014,134(2):364-371.
[12] He Z,Ong CH,Halper J,et al.Progranulin is a mediator of the wound response[J].Nat Med,2003,9(2):225-229.
[13] Tangkeangsirisin W,Serrero G.PC cell-derived growth factor(PCDGF/GP88,progranulin)stimulates migration,invasiveness and VEGF expression in breast cancer cells[J].Carcinogenesis,2004,25(9):1587-1592.
[14] 李媛媛,王红艳,李 森,等.胃癌组织中PGRN和Ki-67免疫反应性增强[J].中国组织化学与细胞化学杂志,2016,25(3):263-266.
[15] Yang D,Wang LL,Dong TT,et al.Progranulin promotes colorectal cancer proliferation and angiogenesis through TNFR2/Akt and ERK signaling pathways[J].Am J Cancer Res,2015,5(10):3085-3097.
[16] Eguchi R,Nakano T,Wakabayashi I.Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells[J].Oncogene,2017,36(5):714-722.
[17] Chen XY,Li JS,Liang QP,et al.Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance[J].Chin Med J(Engl),2008,121(10):881-886.
[18] Dong T,Yang D,Li R,et al.PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts[J].Exp Mol Pathol,2016,100(1):17-25.
[19] Monami G,Emiliozzi V,Bitto A,et al.Proepithelin regulates prostate cancer cell biology by promoting cell growth,migration,and anchorage-independent growth[J].Am J Pathol,2009,174(3):1037-1047.
[20] Cheung ST,Wong SY,Leung KL,et al.Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma[J].Clin Cancer Res,2004,10(22):7629-7636.
[21] Yue S,Gan D,Qian H,et al.Molecular mechanism of macrophages derived from PGRN gene knockout mice inhibit invasion and migration of breast cancer cells[J].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi,2019,35(9):769-775.
[22] Bose D,Zimmerman LJ,Pierobon M,et al.Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells[J].Br J Cancer,2011,105(11):1759-1767.
[23] Wang W,Hayashi J,Serrero G.PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma[J].Clin Cancer Res,2006,12(1):49-56.
[24] Abrhale T,Brodie A,Sabnis G,et al.GP88(PC-Cell Derived Growth Factor,progranulin)stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells[J].BMC Cancer,2011(11):231.
[25] Perez-Juarez CE,Arechavaleta-Velasco F,Zeferino-Toquero M,et al.Inhibition of PI3K/AKT/mTOR and MAPK signaling pathways decreases progranulin expression in ovarian clear cell carcinoma(OCCC)cell line:a potential biomarker for therapy response to signaling pathway inhibitors[J].Med Oncol,2019,37(1):4.
[26] Carlson AM,Maurer MJ,Goergen KM,et al.Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer[J].Cancer Epidemiol Biomarkers Prev,2013,22(10):1730-1735.
[27] Serrero G,Hawkins DM,Yue B,et al.Progranulin(GP88)tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma[J].Breast Cancer Res,2012,14(1):R26.
[28] Koo DH,Do IG,Oh S,et al.Prognostic value of progranulin in patients with colorectal cancer treated with curative resection[J].Pathol Oncol Res,2020,26(1):397-404.
[29] Edelman MJ,Feliciano J,Yue B,et al.GP88(progranulin):a novel tissue and circulating biomarker for non-small cell lung carcinoma[J].Hum Pathol,2014,45(9):1893-1899.
[30] Gobel M,Eisele L,Mollmann M,et al.Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemia[J].PLoS One,2013,8(8):e72107.
[31] Yang D,Li R,Wang H,et al.Clinical implications of progranulin in gastric cancer and its regulation via a positive feedback loop involving AKT and ERK signaling pathways[J].Mol Med Rep,2017,16(6):9685-9691.
[32] Daya M,Loilome W,Techasen A,et al.Progranulin modulates cholangiocarcinoma cell proliferation,apoptosis,and motility via the PI3K/pAkt pathway[J].Onco Targets Ther,2018(11):395-408.
[33] Wang M,Li G,Yin J,et al.Progranulin overexpression predicts overall survival in patients with glioblastoma[J].Med Oncol,2012,29(4):2423-2431.
[34] Yamamoto Y,Goto N,Takemura M,et al.Association between increased serum GP88(progranulin)concentrations and prognosis in patients with malignant lymphomas[J].Clin Chim Acta,2017(473):139-146.
[35] Greither T,Fischer K,Theil G,et al.Expression of GP88(progranulin)in serum of prostate cancer patients is associated with Gleason scores and overall survival[J].Cancer Manag Res,2018(10):4173-4180.
[36] Ho JC,Ip YC,Cheung ST,et al.Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma[J].Hepatology,2008,47(5):1524-1532.
[37] Wong NC,Cheung PF,Yip CW,et al.Antibody against granulin-epithelin precursor sensitizes hepatocellular carcinoma to chemotherapeutic agents[J].Mol Cancer Ther,2014,13(12):3001-3012.
相似文献/References:
[1]文 栋,王西宾△.99Tcm-MDP全身骨扫描及局部单光子发射计算机断层成像在骨转移性肿瘤诊断中的临床应用*[J].陕西医学杂志,2020,49(7):808.[doi:DOI:10.3969/j.issn.10007377.2020.07.010]
WEN Dong,WANG Xibin..Diagnostic value of 99Tcm-MDP whole body bone scan and local SPECT in bone metastatic tumors[J].,2020,49(7):808.[doi:DOI:10.3969/j.issn.10007377.2020.07.010]
[2]杨 旭,张致英,康龙丽,等.环状RNA与代谢性疾病研究进展[J].陕西医学杂志,2021,50(1):126.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.033]
YANG Xu,ZHANG Zhiying,KANG Longli,et al.Advances in circular RNA and metabolic diseases[J].,2021,50(7):126.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.033]
[3]陈正浤,李媛媛,雷光焰,等.Ⅰ型分裂蛋白转导素样增强子在肿瘤中的作用研究进展[J].陕西医学杂志,2021,50(4):511.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.034]
[4]王 琛,齐广莹.Borealin在肿瘤中的作用及其分子机制研究进展[J].陕西医学杂志,2021,50(8):1038.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.034]
[5]黄 静,陈佳茹,喻 莹,等.抑癌基因BLU在肿瘤中的作用及分子机制研究进展[J].陕西医学杂志,2021,50(11):1462.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.035]
HUANG Jing,CHEN Jiaru,YU Ying,et al.Role and molecular mechanism of tumor suppressor gene BLU in tumors[J].,2021,50(7):1462.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.035]
[6]陈 丹,王文静,王庆雅,等.生物发光成像技术在肿瘤细胞活体可视化研究中的应用研究进展[J].陕西医学杂志,2022,51(1):111.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.028]
CHEN Dan,WANG Wenjing,WANG Qingya,et al.Application of bioluminescence imaging technology in visualization of cancer cells in vivo[J].,2022,51(7):111.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.028]
[7]王 剑,魏媛媛,朱利双,等.长链非编码RNA RAB11B-AS1在胶质瘤中的表达及预后价值研究[J].陕西医学杂志,2023,52(4):399.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.008]
WANG Jian,WEI Yuanyuan,ZHU Lishuang,et al.Expression and prognostic value of lncRNA RAB11B-AS1 in glioma[J].,2023,52(7):399.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.008]
[8]黄丽银,斯 韬,梁 婷,等.丙酮酸脱氢酶激酶4在肝细胞癌中的作用研究进展[J].陕西医学杂志,2023,52(7):934.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.036]
HUANG Liyin,SI Tao,LIANG Ting,et al.Research progress on role of pyruvate dehydrogenase kinase 4 in hepatocellular carcinoma[J].,2023,52(7):934.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.036]
[9]李 欣,潘宇飞,万旭英.三氧化二砷在肿瘤治疗中临床应用及相关分子机制研究进展[J].陕西医学杂志,2024,(5):703.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.029]
LI Xin,PAN Yufei,WAN Xuying.Research progress on clinical application and related molecular mechanism of arsenic trioxide in tumor treatment[J].,2024,(7):703.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.029]